Mission Therapeutics Secures $13.3 Million to Advance Parkinson's Disease Trials for MTX325 Mission Therapeutics has successfully raised $13.3 million to push forward clinical trials of MTX325, a promising treatment for Parkinson's disease.

Mission Therapeutics Secures $13.3 Million to Advance Parkinson's Disease Trials for MTX325 #Cambridge #United_Kingdom #Parkinson's_Disease #Mission_Therapeutics #MTX325